Table 1 Clinical, demographic and biochemical data of HCV patients with or without OBI.
| Â | Total HCV Patients | HCV patients with OBI | HCV patients without OBI | p value |
|---|---|---|---|---|
n = 213 | n = 38 | n = 175 | ||
Age (Year), median (range) | 52 (6–80) | 55 (14–78) | 50 (6–80) | >0.05a |
anti-HBs+/anti-HBc+ (%) | 31 (14.6) | 8 (21.1) | 23 (13.1) | >0.05b |
anti-HBs−/anti-HBc+ (%) | 51 (23.9) | 7 (18.4) | 44 (25.1) | >0.05b |
anti-HBs+/anti-HBc− (%) | 23 (10.8) | 5 (13.2) | 18 (10.3) | >0.05b |
anti-HBs−/anti-HBc− (%) | 108 (50.7) | 18 (47.4) | 90 (51.4) | >0.05b |
Sex, M:F | 144:69 | 28:10 | 116:59 | >0.05b |
ALT (IU/L), median (range) | 57.5 (11–237) | 57 (19–117) | 58 (11–237) | >0.05a |
AST (IU/L), median (range) | 76 (19–195) | 76.65 (22–111) | 76 (19–195) | >0.05a |
Total bilirubin (mg/dL), median (range) | 0.97 (0.4–5.8) | 1.14 (0.5–5.4) | 0.9 (0.4–5.8) | >0.05a |
Alkaline phosphatase (IU/L), median (range) | 141 (28–418) | 140 (47.1–400) | 151 (28–418) | >0.05a |
OHBV-DNA (copies/mL), median (range) | NA | 237.1 (10–1056) | NA | NA |
HCV-RNA (copies/mL), median (range) | 92867 (100–5 × 106) | 49100 (100–6.5 × 105) | 281050 (100–5 × 106) | >0.05a |
